The elucidation of the exact events underlying the development of ACPA+ RA might provide relevant insights into the role of T cells and peptide presentation by HLA class II molecules and thereby the pathogenesis of this frequent auto-immune disease. The gene discussed is PRTN3; the disease is rheumatoid arthritis.